RICHARDSON, Texas–(BUSINESS WIRE)–#agenticai–MedeAnalytics, an enterprise healthcare performance company delivering AI-driven data, analytics, and SaaS solutionsRICHARDSON, Texas–(BUSINESS WIRE)–#agenticai–MedeAnalytics, an enterprise healthcare performance company delivering AI-driven data, analytics, and SaaS solutions

MedeAnalytics Appoints Chris Lance as Chief Product Officer

2026/02/03 02:17
4 min read

RICHARDSON, Texas–(BUSINESS WIRE)–#agenticai–MedeAnalytics, an enterprise healthcare performance company delivering AI-driven data, analytics, and SaaS solutions, today announced the appointment of Chris Lance as Chief Product Officer.

Lance brings more than 20 years of experience leading enterprise product and technology organizations, with a proven track record of building scalable platforms and high-performing portfolios that deliver measurable value for payers and providers. As Chief Product Officer, he will lead MedeAnalytics’ product vision, strategy, and execution across its Enterprise Healthcare Performance Cloud.

“Chris is a seasoned product leader with deep healthcare expertise and a strong ability to translate strategy into real-world impact,” said Steve Grieco, CEO of MedeAnalytics. “His experience building platform-based solutions and customer-informed products will be instrumental as we continue advancing our AI-native platform, built on our proprietary Health FabricTM, to help customers move faster from insight to measurable impact.”

“I’m excited to join MedeAnalytics at what I believe is a true inflection point for healthcare,” said Lance. “By connecting trusted data with advanced analytics, AI, and intelligent workflows, MedeAnalytics is uniquely positioned to help organizations manage complexity, move faster, and achieve better outcomes. I look forward to working with the team to build products that turn data into intelligence, intelligence into action, and action into measurable healthcare performance across the ecosystem.”

Prior to joining MedeAnalytics, Lance served as Chief Product Officer at Avalon Healthcare Solutions, where he built high-performing teams, shaped enterprise and product strategy, and delivered innovative laboratory benefit management solutions. He also played a key leadership role in Avalon’s successful sale to WindRose Health Investors.

Before Avalon, Lance was Chief Product Officer at Edifecs, where he led a portfolio of market-leading products. During his tenure, he spearheaded the company’s transition to a cloud-first SaaS business model and, in partnership with the CEO and CFO, facilitated a successful multi-billion-dollar sale of the company to Cotiviti.

Earlier in his healthcare journey, Lance served as Chief Product Officer at Evolent Health, leading the development and delivery of the organization’s health plan administration software and services portfolios. Prior to that, he rose through increasingly senior leadership roles at Change Healthcare, ultimately serving as Head of Product for a broad suite of payer financial management solutions, including Payment Integrity, Clinical Editing, Risk Adjustment, and Value-Based Payments. In these roles, he led multiple business transformation initiatives, including the adoption of platform-based operating models.

Lance began his career outside of healthcare, holding leadership roles across management consulting, general management, product management, sales, and engineering in the manufacturing and brewing industries. This diverse background has shaped his perspective on product leadership, customer value creation, and organizational transformation. He holds an MBA from the Olin School of Business at Washington University in St. Louis and a bachelor’s degree in industrial engineering from Purdue University.

Lance’s appointment underscores MedeAnalytics’ continued investment in product leadership and its commitment to delivering AI-driven, outcome-focused solutions that improve cost efficiency and MLR, strengthen revenue performance, and enhance care outcomes.

About MedeAnalytics

MedeAnalytics is an Enterprise Healthcare Performance company that delivers AI-driven, cloud-native solutions to help payers, providers, and employers measurably improve performance by reducing costs, improving MLR, increasing reimbursement, and elevating care quality. Its enterprise health data management platform—built on our proprietary Health Fabric™—unifies clinical, claims, financial, and social data into a single, scalable source of truth that fuels insights, action, and AI.

As the healthcare intelligence partner of choice for more than 30 years, MedeAnalytics combines comprehensive analytics, AI-powered workflows, and Strategic Advisory™ services to transform intelligence into accountable execution—delivering greater ROI across value-based care, risk and quality, utilization management, network optimization, population health, and revenue cycle operations.

MedeAnalytics empowers organizations to move faster from insight to impact with confidence and measurable results. To learn more, visit medeanalytics.com or follow MedeAnalytics on LinkedIn.

Contacts

Media Contact:
Jonathan Houghton, Dalton Agency
jhoughton@daltonagency.com

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Propel to Report Q4 and Full Year 2025 Financial Results and Announces Dividend Increase

Propel to Report Q4 and Full Year 2025 Financial Results and Announces Dividend Increase

TORONTO, Feb. 10, 2026 /CNW/ – Propel Holdings Inc. (“Propel”) (TSX: PRL), the fintech facilitating access to credit for underserved consumers, announced today
Share
AI Journal2026/02/11 09:15
UK crypto holders brace for FCA’s expanded regulatory reach

UK crypto holders brace for FCA’s expanded regulatory reach

The post UK crypto holders brace for FCA’s expanded regulatory reach appeared on BitcoinEthereumNews.com. British crypto holders may soon face a very different landscape as the Financial Conduct Authority (FCA) moves to expand its regulatory reach in the industry. A new consultation paper outlines how the watchdog intends to apply its rulebook to crypto firms, shaping everything from asset safeguarding to trading platform operation. According to the financial regulator, these proposals would translate into clearer protections for retail investors and stricter oversight of crypto firms. UK FCA plans Until now, UK crypto users mostly encountered the FCA through rules on promotions and anti-money laundering checks. The consultation paper goes much further. It proposes direct oversight of stablecoin issuers, custodians, and crypto-asset trading platforms (CATPs). For investors, that means the wallets, exchanges, and coins they rely on could soon be subject to the same governance and resilience standards as traditional financial institutions. The regulator has also clarified that firms need official authorization before serving customers. This condition should, in theory, reduce the risk of sudden platform failures or unclear accountability. David Geale, the FCA’s executive director of payments and digital finance, said the proposals are designed to strike a balance between innovation and protection. He explained: “We want to develop a sustainable and competitive crypto sector – balancing innovation, market integrity and trust.” Geale noted that while the rules will not eliminate investment risks, they will create consistent standards, helping consumers understand what to expect from registered firms. Why does this matter for crypto holders? The UK regulatory framework shift would provide safer custody of assets, better disclosure of risks, and clearer recourse if something goes wrong. However, the regulator was also frank in its submission, arguing that no rulebook can eliminate the volatility or inherent risks of holding digital assets. Instead, the focus is on ensuring that when consumers choose to invest, they do…
Share
BitcoinEthereumNews2025/09/17 23:52
The Inner Circle acknowledges Catherine B. Murphy as a Pinnacle Professional Member Inner Circle of Excellence

The Inner Circle acknowledges Catherine B. Murphy as a Pinnacle Professional Member Inner Circle of Excellence

PUNTA CANA, Fla., Feb. 10, 2026 /PRNewswire/ — Prominently featured in The Inner Circle, Catherine B. Murphy is acknowledged as a Pinnacle Professional Member Inner
Share
AI Journal2026/02/11 09:45